精氨酸酶
神经退行性变
P70-S6激酶1
海马体
认知功能衰退
生物
化学
内分泌学
神经科学
精氨酸
内科学
PI3K/AKT/mTOR通路
细胞生物学
生物化学
医学
信号转导
疾病
氨基酸
痴呆
作者
Baruh Polis,Kolluru D. Srikanth,Evan Elliott,Hava Gil-Henn,Abraham O. Samson
出处
期刊:Neurotherapeutics
[Springer Science+Business Media]
日期:2018-10-01
卷期号:15 (4): 1036-1054
被引量:96
标识
DOI:10.1007/s13311-018-0669-5
摘要
The urea cycle is strongly implicated in the pathogenesis of Alzheimer's disease (AD). Arginase-I (ARGI) accumulation at sites of amyloid-beta (Aβ) deposition is associated with L-arginine deprivation and neurodegeneration. An interaction between the arginase II (ARGII) and mTOR-ribosomal protein S6 kinase β-1 (S6K1) pathways promotes inflammation and oxidative stress. In this study, we treated triple-transgenic (3×Tg) mice exhibiting increased S6K1 activity and wild-type (WT) mice with L-norvaline, which inhibits both arginase and S6K1. The acquisition of spatial memory was significantly improved in the treated 3×Tg mice, and the improvement was associated with a substantial reduction in microgliosis. In these mice, increases in the density of dendritic spines and expression levels of neuroplasticity-related proteins were followed by a decline in the levels of Aβ toxic oligomeric and fibrillar species in the hippocampus. The findings point to an association of local Aβ-driven and immune-mediated responses with altered L-arginine metabolism, and they suggest that arginase and S6K1 inhibition by L-norvaline may delay the progression of AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI